Dr. Jesus L. Almendral, M.D.
Cardiology (Cardiovascular Disease Physician)
10 Plum St, 7th Floor
New Brunswick, NJ 08901
Who else practices at this address →
Middlesex County includes mental health (21% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 34
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 179
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
NJ license 25MA08921600 · NY license 224499 · PA license MD437226
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Jersey Shore University Medical Center Neptune, NJ
- Jfk University Medical Center Edison, NJ
- Ocean Medical Center Brick, NJ
- Centrastate Medical Center Freehold, NJ
- Riverview Medical Center Red Bank, NJ
Medical groups
- Hackensack Meridian Health Medical Group - Specialty Care PC (1,922 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 179
- Services billed
- 1,513
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 363 | 66 |
| Evaluation of lower heart chamber assist device | 299 | 23 |
| Established patient office or other outpatient visit, 40-54 minutes | 276 | 74 |
| Established patient office or other outpatient visit, 30-39 minutes | 256 | 91 |
| Evaluation of implantable heart and blood vessel monitoring system | 88 | 35 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 60 | 47 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 58 | 26 |
| New patient office or other outpatient visit, 60-74 minutes | 24 | 24 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 18 | 14 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 14 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Entresto (sacubitril/valsartan) Other prescribers in New Brunswick, NJ | 156 |
| Carvedilol Other prescribers in New Brunswick, NJ | 106 |
| Bumetanide Other prescribers in New Brunswick, NJ | 93 |
| Spironolactone Other prescribers in New Brunswick, NJ | 92 |
| Jardiance (empagliflozin) Other prescribers in New Brunswick, NJ | 78 |
| Metoprolol Succinate Other prescribers in New Brunswick, NJ | 76 |
| Atorvastatin Calcium Other prescribers in New Brunswick, NJ | 42 |
| Warfarin Sodium Other prescribers in New Brunswick, NJ | 36 |
| Potassium Chloride Other prescribers in New Brunswick, NJ | 34 |
| Farxiga (dapagliflozin propanediol) Other prescribers in New Brunswick, NJ | 34 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 49 payments worth $1,164 in total to this clinician.
| Abbott Laboratories | $414 |
|---|---|
| E.r. Squibb & Sons, L.l.c. | $141 |
| Abiomed | $112 |
| Pfizer Inc. | $85.81 |
| Merck Sharp & Dohme LLC | $85.25 |
| Bridgebio Pharma, Inc. | $72.13 |
| Alnylam Pharmaceuticals Inc. | $71.78 |
| AstraZeneca Pharmaceuticals LP | $63.44 |
| Food and Beverage | $1,164 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $18,525 in research payments for these studies, mostly to the institutions running them.
- Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics (USA) Inc. · Recruiting · NCT05064709
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.